Tianeptine

[1]  J. Švestka,et al.  Tianeptine versus dosulepine in the treatment of acute depressive disorders. A controlled study , 2000, European Neuropsychopharmacology.

[2]  David Taylor,et al.  Suboptimal Use of Antidepressants in the Treatment of Depression , 2000 .

[3]  N. Cutler,et al.  Gender Differences in Depression and Antidepressant Pharmacokinetics and Adverse Events , 2000, The Annals of pharmacotherapy.

[4]  H. Lôo,et al.  Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine* , 1999, Human psychopharmacology.

[5]  I. Hindmarch,et al.  A double-blind placebo-controlled investigation into the effects of tianeptine and mianserin on psychomotor performance and driving skills , 1999, European Neuropsychopharmacology.

[6]  F. Rouillon.  Anxiety with depression: a treatment need , 1999, European Neuropsychopharmacology.

[7]  J. Costentin,et al.  Although Chemically Related to Amineptine, the Antidepressant Tianeptine Is Not a Dopamine Uptake Inhibitor , 1999, Pharmacology Biochemistry and Behavior.

[8]  B. McEwen,et al.  Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. , 1999, European journal of pharmacology.

[9]  J. Douglas Bremner,et al.  Does stress damage the brain? , 1999, Biological Psychiatry.

[10]  İ. Uzbay,et al.  Analgesic effect of tianeptine in mice. , 1999, Life sciences.

[11]  L. Proust,et al.  Identification of the enzymes involved in the primary pathways of tianeptine using human in vitro models , 1998, European Neuropsychopharmacology.

[12]  B. Mcconville,et al.  Newer antidepressants. Beyond selective serotonin reuptake inhibitor antidepressants. , 1998, Pediatric clinics of North America.

[13]  D. Bakish,et al.  Mixed Anxiety and Depression , 1998, CNS drugs.

[14]  F. Rouillon,et al.  Which patients receive antidepressants? A 'real world' telephone study. , 1998, Journal of affective disorders.

[15]  N. Koshikawa,et al.  Chronic treatment with tianeptine attenuates the behavioural effects induced by 5‐HTP, but not the effects on hippocampal 5‐HT concentrations , 1998 .

[16]  Maya Frankfurt,et al.  Prevention of stress-induced morphological and cognitive consequences , 1997, European Neuropsychopharmacology.

[17]  F. L. Rocha,et al.  Placebo-controlled study of tianeptine in major depressive episodes. , 1997, Neuropsychobiology.

[18]  K. Datla,et al.  Effects of the (+) and (−) Enantiomers of the Antidepressant Drug Tianeptine on 5-HTP-induced Behaviour , 1997, Neuropharmacology.

[19]  B. McEwen,et al.  Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. , 1996, Behavioral neuroscience.

[20]  M. Jouvet,et al.  Effects of tianeptine, sertraline and clomipramine on brain serotonin metabolism: a voltammetric approach in the rat , 1996, Brain Research.

[21]  F. Ferrero,et al.  Controlled Comparison of Tianeptine, Alprazolam and Mianserin in the Treatment of Adjustment Disorders with Anxiety and Depression , 1996 .

[22]  S. Brion,et al.  [Major depressive episodes in patients over 70 years of age. Evaluation of the efficiency and acceptability of tianeptine and mianserin]. , 1996, Presse medicale.

[23]  C. McKittrick,et al.  Tianeptine treatment induces regionally specific changes in monoamines , 1995, Brain Research.

[24]  C. Nemeroff,et al.  Contemporary management of depression. , 1994, The American journal of medicine.

[25]  S. Montgomery.  Clinically relevant effect sizes in depression , 1994, European Neuropsychopharmacology.

[26]  J. Kelly,et al.  The effect of tianeptine and sertraline in three animal models of depression , 1994, Neuropharmacology.

[27]  Bruce S. McEwen,et al.  Repeated stress causes reversible impairments of spatial memory performance , 1994, Brain Research.

[28]  H. Vaudry,et al.  Effect of chronic treatment with the antidepressant tianeptine on the hypothalamo-pituitary-adrenal axis. , 1994, European Journal of Pharmacology.

[29]  F. Artigas,et al.  Effects of the antidepressant drug tianeptine on plasma and platelet serotonin of depressive patients and healthy controls. , 1993, Journal of affective disorders.

[30]  M. Gobbi,et al.  Acute noise stress reduces [3H]5-hydroxytryptamine uptake in rat brain synaptosomes: protective effects of buspirone and tianeptine. , 1993, European journal of pharmacology.

[31]  K. Datla,et al.  Behavioural and neurochemical evidence for the decrease of brain extracellular 5-HT by the antidepressant drug tianeptine , 1993, Neuropharmacology.

[32]  R. Samanin,et al.  Tianeptine raises dopamine and blocks stress-induced noradrenaline release in the rat frontal cortex. , 1993, European journal of pharmacology.

[33]  Y. Watanabe,et al.  Tianeptine attenuates stress-induced morphological changes in the hippocampus. , 1992, European journal of pharmacology.

[34]  Klaus P. Ebmeier,et al.  Estimating pre-morbid intellectual ability in the Alcoholic Korsakoff Syndrome , 1992, Psychological Medicine.

[35]  V. Baudrie,et al.  Differential effects of the novel antidepressant tianeptine on l-5-hydroxytryptophan (5-HTP)-elicited corticosterone release and body weight loss , 1992, European Neuropsychopharmacology.

[36]  A. Manfridi,et al.  In vivo studies on the enhancement of serotonin reuptake by tianeptine , 1992, Brain Research.

[37]  L. Pozzi,et al.  Tianeptine increases the extracellular concentrations of dopamine in the nucleus accumbens by a serotonin-independent mechanism , 1992, Neuropharmacology.

[38]  D. Laude,et al.  Influence of the novel antidepressant tianeptine on neurochemical, neuroendocrinological, and behavioral effects of stress in rats , 1992, Biological Psychiatry.

[39]  V. Caillard,et al.  Sertraline in the Prevention of Depression , 1992, British Journal of Psychiatry.

[40]  H. Vaudry,et al.  The novel antidepressant, tianeptine, reduces stress-evoked stimulation of the hypothalamo-pituitary-adrenal axis. , 1991, European journal of pharmacology.

[41]  B. Renaud,et al.  Increased serotonin platelet uptake after tianeptine administration in depressed patients , 1991, Biological Psychiatry.

[42]  F. Artigas,et al.  Effects of the antidepressant drug tianeptine on plasma and platelet serotonin concentrations in the rat. , 1991, European journal of pharmacology.

[43]  N. Koshikawa,et al.  The effects of tianeptine on wet-dog shakes, fore-paw treading and a flexor reflex in rats are consistent with enhancement of 5-hydroxytryptamine uptake. , 1991, European journal of pharmacology.

[44]  D. Béracochéa,et al.  Effects of tianeptine on spontaneous alternation, simple and concurrent spatial discrimination learning and on alcohol‐induced alternation deficits in mice , 1991, Behavioural pharmacology.

[45]  P. Whitton,et al.  The effect of the novel antidepressant tianeptine on the concentration of 5-hydroxytryptamine in rat hippocampal dialysates in vivo , 1991, Neuropharmacology.

[46]  D. Kupfer,et al.  Five-year outcome for maintenance therapies in recurrent depression. , 1990, Archives of general psychiatry.

[47]  H. Merdjan,et al.  Tianeptine and its main metabolite. Disposition in chronic renal failure and haemodialysis , 1990, Fundamental & clinical pharmacology.

[48]  J. Garrec,et al.  Pharmacokinetics and Bioavailability of Tianeptine in the Elderly , 1990 .

[49]  M. Hamon,et al.  Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain , 1990, Neuropharmacology.

[50]  R. Defrance,et al.  The pharmacokinetics of the antidepressant tianeptine and its main metabolite in healthy humans – influence of alcohol co‐administration , 1990, Fundamental & clinical pharmacology.

[51]  G. Labbe,et al.  Tianeptine, a new tricyclic antidepressant metabolized by beta-oxidation of its heptanoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice. , 1989, Biochemical pharmacology.

[52]  R. Royer,et al.  Tianeptine and its Main Metabolite Pharmacokinetics in Chronic Alcoholism and Cirrhosis , 1989, Clinical pharmacokinetics.

[53]  B. Mcconville,et al.  Beyond Selective Serotonin Reuptake Inhibitor Antidepressants , 1998 .

[54]  D. Sommers,et al.  CHANGES IN THE PROLACTIN RESPONSE TO DEXFENFLURAMINE FOLLOWING TIANEPTINE TREATMENT , 1997 .

[55]  M. Bousoño,et al.  SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. , 1997, Journal of sex & marital therapy.

[56]  J. Mendlewicz,et al.  A double-blind comparison of tianeptine, imipramine and placebo in the treatment of major depressive episodes , 1996, European Psychiatry.

[57]  M. Ziol,et al.  [Acute mixed hepatitis caused by tianeptine]. , 1996, Gastroenterologie clinique et biologique.

[58]  F. Oberti,et al.  [Acute painful and febrile hepatic involvement related to ingestion of tianeptine]. , 1996, Gastroenterologie clinique et biologique.

[59]  F. Rouillon,et al.  Methodological approaches to the long-term study of antidepressants , 1996, European Psychiatry.

[60]  P. Blanc,et al.  Tianeptine--an instance of drug-induced hepatotoxicity predicted by prospective experimental studies. , 1994, Journal of hepatology.

[61]  M. Casacchia,et al.  The efficacy and safety of tianeptine in the treatment of depressive disorder: results of a controlled double-blind multicentre study vs. amitriptyline. , 1994, Neuropsychobiology.

[62]  G. Dunbar,et al.  Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression , 1993, International clinical psychopharmacology.

[63]  J. Guelfi,et al.  Clinical safety and efficacy of tianeptine in 1,858 depressed patients treated in general practice. , 1992, Neuropsychobiology.

[64]  S. File,et al.  Effects of tianeptine in animal models of anxiety and on learning and memory , 1991 .

[65]  J. Guelfi,et al.  Efficacy of tianeptine in anxious-depressed patients: results of a controlled multicenter trial versus amitriptyline. , 1989, Neuropsychobiology.

[66]  H. Lôo,et al.  Tianeptine and amitriptyline. Controlled double-blind trial in depressed alcoholic patients. , 1988, Neuropsychobiology.